Compare RMIX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMIX | CBLL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Building Materials | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 935.3M |
| IPO Year | 2026 | 2024 |
| Metric | RMIX | CBLL |
|---|---|---|
| Price | $12.83 | $23.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.20 |
| AVG Volume (30 Days) | ★ 389.2K | 269.9K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $89,063,000.00 |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | N/A | $28.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $12.88 | $10.85 |
| 52 Week High | $25.50 | $25.63 |
| Indicator | RMIX | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | N/A |
| Support Level | $12.88 | N/A |
| Resistance Level | $18.12 | N/A |
| Average True Range (ATR) | 0.81 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 11.14 | 0.00 |
Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.